AbbVie
Trade AbbVie 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABBV
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.
ABBV Key Statistics
ABBV News
Home Investing Top Dividend Stocks Poised for Explosive Growth in 2026 (ABBV, GD, RGR) Investing Top Dividend Stocks Poised for Explosive Growth in 2026 (ABBV...
In a regulatory filing, the company stated, “Reported GAAP earnings and adjusted non-GAAP earnings for the third quarter of 2025 are expected to include acquire...
St. Louis Financial Planners Asset Management, LLC initiated a new stake in AbbVie (ABBV -0.85%), acquiring 14,630 shares for an estimated $3.39 million in Q3 2...
Analyst ratings
61%
of 31 ratingsMore ABBV News
BofA raised the firm’s price target on AbbVie (ABBV) to $251 from $220 and keeps a Neutral rating on the shares. While the timing of President Trump’s drug pric...
Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powe...
Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock po...
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model ba...
Climb Bio (CLYM) announced the addition of Susan Altschuller, Ph.D., MBA, as Chief Financial Officer. Altschuller served as the Chief Financial Officer of Cerev...
If you are looking for dividend stocks that can provide a reliable, long-term income stream, consider buying AbbVie, Coca-Cola, and Chevron. Stocks in the S&P...
AbbVie (ABBV) announced the start of construction of a $70M expansion at its AbbVie Bioresearch Center in Worcester, Mass., which serves as a center of excellen...